Vaccine for prevention of lyme borreliosis
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F20%3A00532786" target="_blank" >RIV/61388963:_____/20:00532786 - isvavai.cz</a>
Alternative codes found
RIV/68378271:_____/20:00532786
Result on the web
<a href="https://worldwide.espacenet.com/patent/search/family/053373225/publication/EP3139951A1?q=EP3139951" target="_blank" >https://worldwide.espacenet.com/patent/search/family/053373225/publication/EP3139951A1?q=EP3139951</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Vaccine for prevention of lyme borreliosis
Original language description
NOVELTY - Vaccine for treating and preventing Lyme borreliosis for human and veterinary use, comprises: (a) at least one chimeric polyepitope recombinant antigen containing 2-6, preferably 6 immunodominant regions and a terminal region selected from oriented sequences of immunodominant regions of outer surface protein C (Osp) C antigens, (b) at least one chimeric polyepitope recombinant antigen containing 2-7, preferably 7, immunodominant regions and a terminal region selected from oriented sequences of immunodominant regions of OspA antigens, and (c) at least one adjuvant and/or ferritin II. USE - The vaccine is useful for treating and preventing Lyme borreliosis for human and veterinary use or in veterinary and/or human medicine (claimed).
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
10401 - Organic chemistry
Result continuities
Project
<a href="/en/project/GA15-05095S" target="_blank" >GA15-05095S: Study of electronic processes in molecular systems for organic photonics</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
EP3139951
Publisher
EPO_1 -
Publisher name
European Patent Office
Place of publication
Munich, The Hague, Berlin, Vienna, Brussels
Publication country
—
Date of acceptance
Sep 9, 2020
Owner name
Univerzita Palackého v Olomouci - Bioveta, a.s. - Fyzikální ústav AV ČR, v. v. i. - Ústav organické chemie a biochemie AV ČR, v. v. i. - Výzkumný ústav veterinárního lékařství ,v. v. i.
Method of use
B - Výsledek je využíván orgány státní nebo veřejné správy
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence